ei ole lubatud
ei ole lubatud
Digitaalõiguste kaitse (DRM)
Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).
Vajalik tarkvara
Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)
PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )
Seda e-raamatut ei saa lugeda Amazon Kindle's.
1. Nanotechnology and its potential role against viruses
2. Nanotechnology based innovations to fight against viral infections
3. Functionalized metal and metal oxide nanoparticles/nanocomposites against viruses
4. Unique advantages of nanomaterials in drug delivery and therapy against viruses
5. Engineered nanoparticles for therapeutic applications
6. Intranasal delivery of nanoparticles in HIV: A revolution in therapeutics
7. Application of Nanomaterials as Nanomasks
8. Nanomaterials as Sanitizing Agents
Section II Nanotechnology for Detection and Inhibition of Viral Infections
9. Harnessing nanotechnology for visualizing viruses and host-pathogen interactions
10. Nanotechnological tools for the inhibition of Ebola, Zika and Herpes Simplex virus
11. Nanotechnology: New frontiers in anti HIV therapy
12. Nanoparticles based immunoassays for early and rapid detection of HIV and other viral?infections
13. Nanobiotechnology: The union of Sciences in the fight against viruses
Section III Nanotechnology against Novel Coronavirus
14. SARS, MERS and COVID-19: Emerging threats to public health
15. Origin, evolution and pathogenesis of Corona virus
16. Recent advancements in diagnosis, treatment and vaccination for COVID-19
Section IV Nanotechnology-based Vaccines
17. Nanoformulated vaccines against viral infections: a review
18. Development of novel vaccines using nanomaterials against COVID-19
Section V Toxicological challenges
19. Toxicological considerations of use of nanoparticles in the treatment of viral infections